RT Journal Article
SR Electronic
T1 Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management
JF Stroke and Vascular Neurology
JO Stroke Vasc Neurol
FD BMJ Publishing Group Ltd
SP 177
OP 179
DO 10.1136/svn-2020-000398
VO 5
IS 2
A1 Zhou, Yifan
A1 Li, Wei
A1 Wang, David
A1 Mao, Ling
A1 Jin, Huijuan
A1 Li, Yanan
A1 Hong, Candong
A1 Chen, Shengcai
A1 Chang, Jiang
A1 He, Quanwei
A1 Wang, Mengdie
A1 Hu, Bo
YR 2020
UL http://svn.bmj.com/content/5/2/177.abstract
AB Coronavirus disease-2019 (COVID‐19) has become a global pandemic. COVID-19 runs its course in two phases, the initial incubation phase and later clinical symptomatic phase. Patients in the initial incubation phase often have insidious clinical symptoms, but they are still highly contagious. At the later clinical symptomatic phase, the immune system is fully activated and the disease may enter the severe infection stage in this phase. Although many patients are known for their respiratory symptoms, they had neurological symptoms in their first 1–2 days of clinical symptomatic phase, and ischaemic stroke occurred 2 weeks after the onset of the clinical symptomatic phase. The key is to prevent a patient from progressing to this severe infection from mild infection. We are sharing our experience on prevention and management of COVID-19.